Drug Metabolism and Disposition
Издатель: Elsevier · ISSN 0090-9556 · 32 статей
- Human cytochrome P450 27A1—a variety of reactions, applications, and potentials for drug targeting
- A SYSTEMATIC SURVEY OF COMPUTATIONAL DRUG–DRUG INTERACTION PREDICTION: PROBLEM FORMULATIONS, DATA CHALLENGES, AND SCALABLE ARCHITECTURES
- Biotransformation and Disposition of Inavolisib, a Selective PI3Kɑ Inhibitor, in Humans
- In Vitro-In Vivo Extrapolation of Hepatic Clearance for GalNAc-siRNA Therapeutics Using Rat Liver Tritosomes
- The Relationship Between Age and Endogenous Biomarkers of Organic Anion Transporters 1 and 3 (OAT1/3) in Preterm Neonates: A Cross-sectional Study
- Evaluation of a Long-Term Human Hepatocyte Culture Maintained in PowerHEP Maintenance Medium for Drug Clearance Prediction
- Systematic Evaluation of Organoid Fidelity for ADME and Toxicity Assessment
- A Targeted Tandem Mass Spectrometry Based Bottom-Up Proteomic Approach Incorporating Hydrophobicity Matched Internal Standards to Evaluate Brigatinib-Induced Drug Metabolism Enzymes and Transporters Modulation
- Investigation of the pharmacokinetics, metabolism, and clearance pathways of a heterobifunctional BRM degrader delivered by a TROP2-targeting antibody
- Hepatocyte-Based Models for CYP450 Fraction Metabolized Determination: Recommendations from the Quantitative Fraction Metabolized IQ Consortium Working Group
- Editorial for Virtual Special Section: Endogenous Biomarkers of Drug-Metabolizing Enzymes and Transporters
- Full Mass Spectrum Background Subtraction in LC–HRMS Drug Metabolite Profiling: Untargeted Detection, Integrated Structural Characterization, and Applications
- Review of the selectivity of chlorzoxazone 6-hydroxylation as a probe for human cytochrome P450 2E1
- Multidimensional regulation of the cytochrome P450 metabolic network in pulmonary arterial hypertension: Homeostatic imbalance, pathological drivers, and environmental interactions
- Functional characterization of rare DPYD variants identified in 8,380 Japanese individuals: implications for 5-fluorouracil metabolism
- Impact of nonspecific binding to membrane vesicles on unbound IC50 estimation for P-glycoprotein and breast cancer resistance protein inhibitors and implications for drug-drug interaction risk assessment
- A practical framework to predict human hepatic clearance for Extended Clearance Classification System class 1B acidic and zwitterionic drugs
- A previously undetected major circulating metabolite of trazpiroben revealed by human radiolabeled absorption, distribution, metabolism, and excretion study
- Evaluation of deuterium isotope effects on the metabolism of 10 drugs across multiple human cytochrome P450 enzymes: considerations for drug design
- Monocarboxylate transporter 6 mediates sex-dependent cisplatin ototoxicity via metabolite uptake
- Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective Bruton tyrosine kinase inhibitor, in healthy participants at steady state
- Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin
- Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing
- Investigation of the Nonlinear Pharmacokinetics of Vismodegib in Humans: Using PBPK Modeling to Examine Contributions of Saturable Plasma Protein Binding and Nonsink Permeation
- Absorption, distribution, metabolism, and excretion of the BMS-986365 ligand-directed degrader diastereomers, R,R-[14C]BMS-986409 and R,S-[14C]BMS-986410, following oral administration in combination with an intravenous microtracer in healthy male participants
- Systematic search on fat free mass and fat mass in exclusively breastfed infants until one year of age – a contribution from the ConcePTION project
- Quantitative determination of lysosomal accumulation fraction, flyso, for estimating Kp,uu,brain tumor and target coverage for drugs treating human glioblastoma
- Discovery, Evolution, and Applications of Mass Defect Filtering in Drug Metabolite Identification
- Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota
- Species differences in loxoprofen reductase activities: Roles of aldo-keto and carbonyl reductases in humans and rats